GMDI is pleased to announce the GMDI 2026 Conference will take place on April 22-25, 2026, in St. Louis, Missouri, USA. We welcome abstracts that communicate unpublished research, case studies, educational tools, development of new services and clinics, and public policy efforts that are relevant to the nutritional management of inherited metabolic diseases.

Abstract Submission Deadline: December 15, 2025 11:59PM EST
Abstracts submitted after this deadline will not be considered.
(OPTIONAL) Preliminary Abstract Review:
  • This option is now available for authors:
    • Who are submitting an abstract for the first time
    • Who work in settings with minimal research mentorship
    • For whom English is not their first language
  • Preliminary Abstract Review Submission Deadline: October 6, 2025 11:59PM EST. Abstracts submitted after this deadline will not be considered for preliminary review.
  • Abstracts submitted for preliminary review will be reviewed by the GMDI Research Committee and constructive feedback will be provided via e-mail by November 10, 2025.
  • Abstracts submitted for preliminary review will not be considered as the final versions and revised abstracts will need to be resubmitted by the December 15, 2025 deadline. Acceptance of revised abstracts is not guaranteed.
Abstract Requirements:
Please be sure to read the Abstract Submission Guidelines published on the GMDI website BEFORE submitting your abstract. Because the accepted abstracts will be published, the GMDI Research Committee will not accept abstracts that do not follow the instructions described in this document.

Question Title

* 1. Please select one option from the list below.

Question Title

* 2. Abstract Title [The first letter of the first word in the title should be capitalized.  Please do not use all CAPS]

Question Title

* 3. Name of submitter/first author  (last name, first name)

Question Title

* 4. Email address of first author

Question Title

* 5. Phone Number of first author

Notes: 
  • The first author of the abstract is the presenting author and will be expected to attend the conference for poster or oral presentation.
  • Multiple abstracts can be submitted by the same presenting author but must address different research/cases
  • Affiliations must be indicated for each author using superscript numbers and should include the Department, Hospital or University, City, State/Province, Country.
  • It is the presenting author’s responsibility to ensure that all co-authors agree with the abstract submission and publication.

Question Title

* 6. Author(s) initials followed by their last name; if authors have different or multiple affiliations, please include an affiliation number, and provide details for each affiliation below. Example: AB Snow 1, CD Ice2, EF Heat1 and GH Warm 1,3. [Include first author in this list]

Question Title

* 7. Affiliation: Please enter details for each Affiliation [Department, Institution, City, State/Province, Country] below. Numbers should refer to the affiliation noted for each author in the previous question. As in the previous example, AB Snow, EF Heat and GH Warm all work at the same institution, denoted "1". Their affiliation should be listed below as 1. The affiliation for CD Ice should be listed below as 2., and the second affiliation for GH Warm should be listed below as 3.

Question Title

* 8. Organize the abstract using the headings shown in the examples provided. Abstracts must be written in English using complete sentences. Do not include tables or figures. The word limit for abstracts is 350 words.

Notes:
  • Include funding disclosures and/or clinical trial registration information as appropriate.
  • The presenting author is responsible for disclosing the presence or absence of conflict(s) of interest and financial disclosures for all authors during the abstract submission.

Question Title

* 9. Please indicate if any of the authors has a potential conflict of interest.

Question Title

* 10. Funding Disclosure(s)
Please include funding disclosures as appropriate.

Question Title

* 11. Clinical Trial Registration (if appropriate)

Question Title

* 12. Please check below

Question Title

* 13. Please select a topic group for your abstract. Selecting a topic does not impact the decision for platform or poster presentation acceptance.

T